Adma Biologics (ADMA) Current Taxes (2024 - 2025)

Adma Biologics (ADMA) posted Current Taxes of $8.6 million for Q4 2025, up 209.04% on a QoQ basis from $2.8 million in Q3 2025, and up 147.52% year-over-year from $3.5 million in Q4 2024.

Adma Biologics (ADMA) Current Taxes (2024 - 2025) Analysis & Trends

Adma Biologics' Current Taxes history runs 2 years deep, the most recent figure standing at $8.6 million for Q4 2025.

  • Quarterly Current Taxes rose 147.52% year-over-year to $8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.6 million (up 147.52% YoY) and the FY2025 annual result came in at $8.6 million, up 147.52% from the prior year.
  • Current Taxes was $8.6 million for Q4 2025 at Adma Biologics, up from $2.8 million in the prior quarter.
  • Across five years, Current Taxes topped out at $8.6 million in Q4 2025 and bottomed at $2.7 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 63.52 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 49.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Adma Biologics 1.99 Bn 1.91 Bn 88.82 Mn 8.62 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8.62 Mn
Sep 30, 2025 2.79 Mn
Jun 30, 2025 2.70 Mn
Mar 31, 2025 6.60 Mn
Dec 31, 2024 3.48 Mn
Jun 30, 2024 2.83 Mn